日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered FnCas12a with enhanced activity through directional evolution in human cells

通过在人类细胞中进行定向进化,构建了活性增强的工程化FnCas12a。

Liu, Xiexie; Liu, Xiaoyu; Zhou, Chenchen; Lv, Jineng; He, Xiubin; Liu, Yuanyuan; Xie, Haihua; Wang, Bang; Lv, Xiujuan; Tang, Lianchao; Li, Mingchun; Liu, Changbao; Zhao, Junzhao; Liu, Yong; Song, Zongming; Gu, Feng

Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells.

高效切割可解决 CRISPR-Cas 在人类细胞中的 PAM 偏好性

Tang Lianchao, Yang Fayu, He Xiaoxue, Xie Haihua, Liu Xiaoyu, Fu Junhao, Xi Haitao, Lu Xiaosheng, Liu Changbao, Song Zongming, Qu Jia, Zhao Junzhao, Gu Feng

Engineering the Direct Repeat Sequence of crRNA for Optimization of FnCpf1-Mediated Genome Editing in Human Cells

通过改造crRNA的直接重复序列来优化FnCpf1介导的人类细胞基因组编辑

Lin, Li; He, Xiubin; Zhao, Tianyuan; Gu, Lingkai; Liu, Yeqing; Liu, Xiaoyu; Liu, Hongyan; Yang, Fayu; Tu, Mengjun; Tang, Lianchao; Ge, Xianglian; Liu, Changbao; Zhao, Junzhao; Song, Zongming; Qu, Jia; Gu, Feng